# ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis

> **NCT01097668** · PHASE1 · COMPLETED · sponsor: **Apitope Technology (Bristol) Ltd.** · enrollment: 43 (actual)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** ATX-MS-1467

## Key facts

- **NCT ID:** NCT01097668
- **Lead sponsor:** Apitope Technology (Bristol) Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2015-02-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01097668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01097668, "ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01097668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*